- Home
- ATOS vs HFBL Comparison
ATOS vs HFBL Comparison
Compare ATOS & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATOS | HFBL |
|---|---|---|
| Founded | 2009 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2M | 41.6M |
| IPO Year | 2010 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ATOS | HFBL |
|---|---|---|
| Price | $4.46 | $18.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $31.67 | N/A |
| AVG Volume (30 Days) | ★ 116.6K | 2.3K |
| Earning Date | 04-20-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | ★ 16.67 | 7.69 |
| EPS | N/A | ★ 1.07 |
| Revenue | $1,758.00 | ★ $1,303,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.04 |
| Revenue Growth | N/A | ★ 17.49 |
| 52 Week Low | $0.53 | $12.31 |
| 52 Week High | $7.56 | $20.00 |
Technical Indicators
Market Signals| Indicator | ATOS | HFBL |
|---|---|---|
| Relative Strength Index (RSI) | 61.36 | 49.46 |
| Support Level | $3.80 | $12.87 |
| Resistance Level | $7.56 | $19.20 |
| Average True Range (ATR) | 0.35 | 0.19 |
| MACD | -0.10 | -0.07 |
| Stochastic Oscillator | 56.23 | 13.12 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.